Found 64 articles for: "topical"
Topical Vehicle Design: Educational Intervention Addresses Gap in Dermatology Resident Training
April 2026 | Volume 25 | Issue 4 | Editorials | e41 | Copyright © April 2026
Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema
March 2026 | Volume 25 | Issue 3 | Original Article | 228 | Copyright © March 2026
Background: Chronic hand eczema (CHE) is a common, heterogeneous inflammatory skin disease associated with substantial symptom burden, impaired hand function, reduced quality of ...
Read MoreAdvanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert Panel
March 2026 | Volume 25 | Issue 3 | Original Article | 221 | Copyright © March 2026
Background: Advanced topical nonsteroidal therapies are expanding options for atopic dermatitis (AD) by providing targeted anti-inflammatory control without many limitations of l...
Read MoreScar Wars: A Review of Topical Scar Therapies
December 2025 | Volume 24 | Issue 12 | Features | 1265 | Copyright © December 2025
Visualization of Topical Roflumilast Versus Vehicle using Line-Field Optical Coherence Tomography in Healthy Skin
November 2025 | Volume 24 | Issue 11 | Original Article | 1126 | Copyright © November 2025
Background: Roflumilast is a topical phosphodiesterase-4 inhibitor FDA-approved for treating plaque psoriasis and atopic dermatitis. Line-field confocal optical coherence tomogra...
Read MoreCaffeine Supplementation and Hair: A Systematic Review
November 2025 | Volume 24 | Issue 11 | Original Article | 1070 | Copyright © November 2025
Background: While caffeine has been proposed to stimulate hair growth, its safety and efficacy remain unclear. This systematic review evaluates the effects of caffeine interventi...
Read MoreManagement of Hailey-Hailey Disease With Ruxolitinib 1.5% Cream
November 2025 | Volume 24 | Issue 11 | Case Reports | 1141 | Copyright © November 2025
Introduction: Benign Familial Pemphigus (Hailey-Hailey Disease [HHD]) is a rare chronic condition, with treatments focusing on managing disease symptoms.Case...
Read MoreSkin Barrier Benefits of a Natural Moisturizing Factor and Lipids-Based Moisturizer for Clinically Sensitive Skin
October 2025 | Volume 24 | Issue 10 | Original Article | 1029 | Copyright © October 2025
Read MoreRuxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Original Article | 1036 | Copyright © October 2025
Atopic dermatitis (AD), a chronic inflammatory skin disease, is typically treated with topical corticosteroids in patients with mild to moderate disease, creating an ongoing need for nonsteroidal...
Read MoreUnderstanding Topical Steroid Withdrawal: Where Are We Now?
October 2025 | Volume 24 | Issue 10 | Features | 1057 | Copyright © October 2025
Eyelid Position and Patient-Reported Aesthetic Outcomes Following Administration of Topical Oxymetazoline: A Prospective Cohort Investigation
September 2025 | Volume 24 | Issue 9 | Original Article | 885 | Copyright © September 2025
Background: Topical oxymetazoline hydrochloride 0.1% is a pharmacologic agent for eyelid elevation.Objective: This study investigates changes in eye...
Read MoreSafety and Tolerability of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Truncal Acne
August 2025 | Volume 24 | Issue 8 | Original Article | 803 | Copyright © August 2025
Background: Truncal acne is underdiagnosed and undertreated, and it can lead to scarring and postinflammatory hyperpigmentation. However, applying topical treatments to larger sk...
Read MorePrecision, Research, Progress: Updates in the Management of Pityriasis Rubra Pilaris
August 2025 | Volume 24 | Issue 8 | Features | 833 | Copyright © August 2025
Commonly Prescribed Hair Loss Treatments Are Rarely Designated as Dermatologic Agents by Insurance Companies
August 2025 | Volume 24 | Issue 8 | Editorials | e53 | Copyright © August 2025
Deucravacitinib With Add-On Calcipotriene/Betamethasone Dipropionate for Treating Moderate to Severe Plaque Psoriasis
August 2025 | Volume 24 | Issue 8 | Original Article | 744 | Copyright © August 2025
Background: To assess the effectiveness, safety, and quality of life in patients who received topical calcipotriene/betamethasone dipropionate (C/BD) foam added to oral deucravacitini...
Read MoreClinical Profile of Halobetasol Propionate 0.01%/ Tazarotene 0.045% Lotion in Patients With Hyperkeratotic Plaque Psoriasis
June 2025 | Volume 24 | Issue 6 | Original Article | 590 | Copyright © June 2025
Background: Hyperkeratotic psoriatic plaques, characterized by considerable elevation and scaling, present treatment challenges with topical therapy. This post hoc analysis of tw...
Read MorePractical Algorithm on Topical Treatment of Flaring Atopic Dermatitis (AD) With or Without Secondary Infection
June 2025 | Volume 24 | Issue 6 | Original Article | 621 | Copyright © June 2025
Acute exacerbations or flares are a key characteristic of atopic dermatitis (AD), often associated with sleep deprivation, as well as experiences of stigmatization, social withdrawal, anxiety, an...
Read MoreNeed for Speed: Topical Roflumilast for Rapid Control of Seborrheic Dermatitis Flares
June 2025 | Volume 24 | Issue 6 | Case Reports | 634 | Copyright © June 2025
Seborrheic dermatitis is a common chronic inflammatory skin condition historically treated with topical antifungals and anti-inflammatory agents. While topical corticosteroids are frequently used...
Read MoreRandomized-Controlled Trial Comparing Safety and Efficacy of Repairing Balm vs Topical Antimicrobial for Post-Procedural Wounds
May 2025 | Volume 24 | Issue 5 | Original Article | 507 | Copyright © May 2025
Background: Actinic keratoses (AK) are pre-cancerous, intraepidermal lesions that exist on a continuum with squamous cell carcinoma. Cryotherapy using liquid nitrogen freezi...
Read MoreTopical Corticosteroid Potencies: Reimagining A New Universal Classification System
May 2025 | Volume 24 | Issue 5 | Original Article | 458 | Copyright © May 2025
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
